FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 1 filers reported holding FLEXION THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,561,000 | -25.9% | 1,403,370 | 0.0% | 0.44% | -13.5% |
| Q2 2021 | $11,550,000 | -8.0% | 1,403,370 | 0.0% | 0.51% | -1.3% |
| Q1 2021 | $12,560,000 | -22.4% | 1,403,370 | 0.0% | 0.52% | -25.2% |
| Q4 2020 | $16,195,000 | +10.9% | 1,403,370 | 0.0% | 0.69% | -4.3% |
| Q3 2020 | $14,609,000 | -20.8% | 1,403,370 | 0.0% | 0.72% | -39.1% |
| Q2 2020 | $18,454,000 | -49.1% | 1,403,370 | -6.4% | 1.19% | -74.8% |
| Q3 2017 | $36,270,000 | +19.6% | 1,500,000 | 0.0% | 4.72% | +30.1% |
| Q2 2017 | $30,330,000 | -19.4% | 1,500,000 | +7.3% | 3.63% | -9.4% |
| Q1 2017 | $37,613,000 | +41.5% | 1,397,718 | 0.0% | 4.00% | +58.2% |
| Q4 2016 | $26,585,000 | +23.9% | 1,397,718 | +27.3% | 2.53% | +32.9% |
| Q3 2016 | $21,449,000 | +50.8% | 1,097,718 | +15.5% | 1.90% | +27.6% |
| Q2 2016 | $14,224,000 | -7.3% | 950,161 | -8.0% | 1.49% | -5.9% |
| Q3 2015 | $15,352,000 | -67.1% | 1,033,131 | -51.6% | 1.59% | -52.8% |
| Q2 2015 | $46,694,000 | -9.2% | 2,133,131 | -6.6% | 3.36% | -23.2% |
| Q1 2015 | $51,416,000 | +11.5% | 2,283,131 | 0.0% | 4.37% | +17.3% |
| Q4 2014 | $46,096,000 | +41.6% | 2,283,131 | +28.0% | 3.73% | +17.4% |
| Q3 2014 | $32,560,000 | -32.3% | 1,783,131 | -50.0% | 3.18% | +31.9% |
| Q2 2014 | $48,074,000 | -18.1% | 3,566,262 | 0.0% | 2.41% | -34.3% |
| Q1 2014 | $58,666,000 | – | 3,566,262 | – | 3.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|